sanjeev

Randeep Hooda says Bollywood is ‘threatened’ by him, ignored his meaty role in Extraction while other actors do major campaigns for tiny parts in Hollywood: ‘I got no work’

by

Randeep Hooda and Chris Hemsworth in a still from Extraction. (Pic: IMDB) Bollywood actor Randeep Hooda landed his first Hollywood role in Joe Russo and Anthony Russo’s film Extraction, where he shared screen space with Avengers star Chris Hemsworth. Randeep played a major character and also got substantial screen time in the film. However, in a recent … Read more

‘Enemies Of Dr Babasaheb Ambedkar’: Congress Hits Back At PM Modi’s ‘Votebank Ka Virus’ Charge

by

New Delhi: Calling the Bharatiya Janata Party the “enemies of Babasaheb then and even now,” the Congress party hit back at Prime Minister Narendra Modi on Monday for the latter’s remark accusing the party of spreading “votebank ka virus” by opposing the Waqf Amendment Act. Congress party’s president Mallikarjun Kharge, while addressing a press conference in … Read more

Abhishek Banerjee on being part of four major franchises – Stree, Bhediya, Mirzapur and Dream Girl, ‘It’s exciting to reprise roles that are so close to my heart’

by

In just last six years, Abhishek Banerjee has become a cornerstone of Bollywood’s biggest franchises, carving out a unique space for himself in the industry. With his unique acting prowess and ability to seamlessly adapt to diverse roles, the actor is now associated with four major franchises that promise to dominate the big screen in … Read more

Love isn’t blind-at least not to debt: 5 money habits to spot in your partner

by

As wedding bells ring, Indian brides are waking up to the reality of money harmony. With inflated living costs, dual-income families, and web-like financial obligations, money merging and efficient management is no longer an option-it’s a necessity. That is why going through these five easy money habits is a must-read for every Indian couple to … Read more

PL Capital cuts Nifty targets; removes Infy, RIL, L&T from high conviction picks

by

Domestic brokerage PL Capital has trimmed its targets for Nifty50 index, while making some key rejigs in its model portfolio, which includes select high conviction picks across various sectors. It has removed select growth, export and crude-related stocks, with remaining positive on consumption, consumer spending and staples. Nifty50 index has experienced a 3.8 per cent … Read more

Vedanta asked to pay Rs 71 cr over fly ash effluent

by

New Delhi: Vedanta has said that State Pollution Control Board, Odisha, has asked it to deposit a compensation of Rs 71.1 crore for unauthorised disposal of fly ash. Fly ash is a fine, powdery waste material created when coal is burned in power plants. “The issue pertains to allegation for unauthorised disposal of fly ash. … Read more

Indian Air Force Plane On Myanmar Relief Ops Faced Big Cyberattack, Then This Happened

by

New Delhi: An Indian Air Force carrying relief material to earthquake-hit Myanmar last month intercepted ‘GPS spoofing’, and the pilot’s timely action saved the aircraft from any untoward incident, revealed Defence sources, as per PTI. It was not clear if the attempt of GPS spoofing was made on all the six aircraft, but the pilot of … Read more

₹2.25 crore or ₹84,658/month? Govt employees face pension fork as advisor sounds June alarm

by

₹2.25 crore or ₹84,658 per month for life? That’s the retirement riddle facing Central Government employees, who must choose between the National Pension System (NPS) and the Unified Pension Scheme (UPS) by June 2025. SEBI-registered investment advisor Abhishek Kumar flagged the dilemma in a recent LinkedIn post, asking: “Which one would you pick?” The stakes … Read more

Celltrion gets interchangeability approval for biosimilar of Humira in US

by

Celltrion, a major South Korean biopharmaceutical firm, on Monday said it has obtained an interchangeability approval for its biosimilar drug for autoimmune disease treatment in the United States. The US Food and Drug Administration (FDA) designated Celltrion’s biosimilar Yuflyma as interchangeable medicine for its original drug Humira in the US, Yonhap news agency reported. Interchangeability … Read more